Structure and stability of DNA containing an aristolactam II-dA lesion: implications for the NER recognition of bulky adducts

Intercalative Conformations of the 14R(+)- and 14S(−)-trans-anti-DB[a,l]P-N6-dA Adducts: Molecular Modeling and MD Simulations

(2011) Yuqin Cai et al.   CHEMICAL RESEARCH IN TOXICOLOGY

The human carcinogen aristolochic acid i is activated to form DNA adducts by human NAD(P)H:quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases

(2011) Marie Stiborová et al.   ENVIRONMENTAL AND MOLECULAR MUTAGENESIS

TP53 Mutational signature for aristolochic acid: an environmental carcinogen

(2011) Masaaki Moriya et al.   INTERNATIONAL JOURNAL OF CANCER

Resistance of bulky DNA lesions to nucleotide excision repair can result from extensive aromatic lesion–base stacking interactions

(2011) Dara A. Reeves et al.   NUCLEIC ACIDS RESEARCH

Base Flipping Free Energy Profiles for Damaged and Undamaged DNA

(2010) Han Zheng et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Stereoselective Nucleoside Deuteration for NMR Studies of DNA

(2010) Mark Lukin et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Solution structure of DNA containing α-OH-PdG: the mutagenic adduct produced by acrolein

(2009) Tanya Zaliznyak et al.   NUCLEIC ACIDS RESEARCH

DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells

(2009) Sivaprasad Attaluri et al.   NUCLEIC ACIDS RESEARCH

TP53mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours

(2008) Tatiana Nedelko et al.   INTERNATIONAL JOURNAL OF CANCER

Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy

(2007) Marie Stiborová et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH